LOW BONE MASS IN CHILDREN WITH MALIGNANT LYMPHOMA

REFERENCES

• Hui S L, Slemenda C W, Johnston C C. The contribution of bone loss of postmenopausal osteoporosis. Osteoporosis Int 1990; 1: 30–34
   PubMedGoogle Scholar
• Atkinson S A, Fraher L, Gundberg C M, Andrew M, Pai M, Barr R D. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr 1989; 114: 793–800
   PubMed Web of Science ®Google Scholar
• Halton J M, Atkinson S A, Fraher L. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 1996; 11: 1774–1783
   PubMed Web of Science ®Google Scholar
• Haddy T B, Mosher R B, Reaman G H. Osteoporosis in survivors of acute lymphoblastic leukemia. Oncologist 2001; 6: 278–285
   PubMed Web of Science ®Google Scholar
• Wiernikowski J T, Barr R D, Webber C, Guo C Y, Wright M, Atkinson S A. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study. J Oncol Pharm Pract 2005; 11: 51–56
   PubMedGoogle Scholar
• Cohn S L, Morgan E R, Mallette L E. The spectrum of metabolic bone disease in lymphoblastic leukemia. Cancer 1987; 59: 346–350
   PubMed Web of Science ®Google Scholar
• Samuda G M, Cheng M Y, Yeung C Y. Back pain and vertebral compression: an uncommon presentation of childhood acute lymphoblastic leukemia. J Pediatr Orthop. 1987; 7: 175–178
   Google Scholar
• Halton J M, Atkinson S A, Fraher L. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 1995; 126: 557–264
   PubMed Web of Science ®Google Scholar
• Kobayashi D, Satsuma S, Kamegaya M. Musculoskeletal conditions of acute leukemia and malignant lymphoma in children. J Pediatr Orthop B 2005; 14: 156–161
   PubMed Web of Science ®Google Scholar
• Akber J, Gallagher M T, Matthew L, Ayoub D, Miale T D. Destructive skeletal lesions as the primary initial manifestation of acute childhood leukemia. Am J Pediatr Hematol Oncol 1988; 10: 258–260
   PubMedGoogle Scholar
• Warner J T, Evans W D, Webb D K, Bell W, Gregory J W. Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res 1999; 45: 544–551
   PubMed Web of Science ®Google Scholar
• Kaste S C, Jones-Wallace D, Rose SR. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia 2001; 15: 728–734
   PubMed Web of Science ®Google Scholar
• Lequin MH, van der Shuis IM, Van Rijn RR. Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood. J Clin Densitom 2002; 5: 167–173
   PubMed Web of Science ®Google Scholar
• Schwartz A M, Leonidas J C. Methotrexate osteopathy. Skeletal Radiol 1984; 11: 13–16
   PubMed Web of Science ®Google Scholar
• Kelly J, Damron T, Grant W. Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers. J Pediatr Hematol Oncol 2005; 27: 248–253
   PubMed Web of Science ®Google Scholar
• Gilsanz V, Carlson M E, Roe T F, Ortega J A. Osteoporosis after crania irradiation for acute lymphoblastic leukemia. J Pediatr 1990; 117: 238–244
   PubMed Web of Science ®Google Scholar
• Hyer S L, Rodin D A, Tobias J H, Leiper A, Nussey S S. Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child 1992; 67: 1472–1474
   PubMed Web of Science ®Google Scholar
• Atkinson S A, Halton J M, Bradley C, Wu B, Barr R D. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer 1998; 11(suppl): 35–39
   Google Scholar
• Meijer W G, Van Der Veer E, Willemse P H. Biochemical parameters of bone metabolism in bone metastases of solid tumors. Oncol Rep 1998; 5: 5–21
   PubMed Web of Science ®Google Scholar
• Binkley N, Bilezikian J P, Kendler D L, Leib E S, Lewiecki E M, Petak S M. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom 2006; 9: 4–14
   PubMed Web of Science ®Google Scholar
• Power M J, Forttrell P F. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 1991; 28: 287–335
   PubMed Web of Science ®Google Scholar
• Reid I R, Ames R W, Evans M C, Gamble G D, Sharpe S J. Longterm effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995; 98: 331–335
   PubMed Web of Science ®Google Scholar
• Bouillon R, Coopmans W, Degroote DEH, Radoux D, Eliard P. Immunoradioreactive assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem 1990; 36: 271–276
   PubMed Web of Science ®Google Scholar
• Ooms M E, Lips P, Roos J C. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 1995; 10: 1177–1184
   PubMed Web of Science ®Google Scholar
• Preece M A, Tomlinson S, Ribot C A. Studies of vitamin D deficiency in man. Q J Med 1975; 44: 575–589
   PubMedGoogle Scholar
• Nussey S, Hyer S, Brada M, Leiper A, Pazianas M. Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatr 1994; 399(Suppl)9–14
   Google Scholar
• Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kröger H. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab 1999; 84: 3174–3181
   PubMed Web of Science ®Google Scholar
• Arikoski P, Komulainen J, Riikonen P, Jurvelin J S, Voutilainen R, Kröger H. Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child 1999; 80: 143–148
   PubMed Web of Science ®Google Scholar
• Nysom K, Holm K, Michaelsen K F, Hertz H, Muller J, Molgaard C. Bone mass after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 2001; 37: 518–524
   PubMedGoogle Scholar
• Arikoski P, Kroger H, Riikonen P, Parviainen M, Voutilainen R, Komulainen J. Disturbance in bone turnover in children with a malignancy at completion of chemotherapy. Med Pediatr Oncol 1999; 33: 455–461
   PubMedGoogle Scholar